The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 119.85%. However, over the past six months, we’ve seen a weaker performance of 40.33%. The price of BCLI fallen by 65.34% over the last 30 days. And in the last five days, it has surged by 18.38%.
In terms of market performance, Brainstorm Cell Therapeutics, Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $3.46 on 03/31/23, while the lowest value was $0.13 on 10/31/23.
52-week price history of BCLI Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Brainstorm Cell Therapeutics, Inc.’s current trading price is -82.65% away from its 52-week high, while its distance from the 52-week low is 347.91%. The stock’s price range over this timeframe has been between $0.13 and $3.46. The shares of the Healthcare sector company recorded a trading volume of approximately 1.28 million for the day, which was comparatively higher than the average daily volume of 1.1 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Brainstorm Cell Therapeutics, Inc. (BCLI) has experienced a quarterly rise of 160.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 29.40M and boasts a workforce of 43 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.3045, with a change in price of +0.4502. Similarly, Brainstorm Cell Therapeutics, Inc. recorded 2,046,058 in trading volume during the last 100 days, posting a change of +300.13%.
BCLI Stock Stochastic Average
Brainstorm Cell Therapeutics, Inc.’s raw stochastic average for the past 50 days is currently at 63.17%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 63.17%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.48% and 77.84%, respectively.
